Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
Disability and Rehabilitation|May 25, 2010
Gardening with Huntington's disease clients--creating a programme of winter activitiesJosephine Anne Spring, Mark Baker, Loreane Dauya, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2025
Hyperforin potentiates polymyxin B against multidrug-resistant Gram-negative pathogens via membrane disruption, biofilm eradication, and oxidative stressMaytham Hussein, Simon Crawford, Mark Baker, et al.
Molecules (Basel, Switzerland)|June 10, 2015
Molecular Characterisation of the Haemagglutinin Glycan-Binding Specificity of Egg-Adapted Vaccine Strains of the Pandemic 2009 H1N1 Swine Influenza A VirusVincenzo Carbone, Elena K Schneider, Steve Rockman, et al.
Computational and Structural Biotechnology Journal|March 14, 2022
Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant Klebsiella pneumoniaeMaytham Hussein, Labell J M Wong, Jinxin Zhao, et al.
The Lancet. Infectious Diseases|October 9, 2015
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trialAung Pyae Phyo, Podjanee Jittamala, François H Nosten, et al.
Anti-Cancer Drugs|March 27, 2002
In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and IIPrakash Mistry, Alistair J Stewart, Wendy Dangerfield, et al.
Computational and Structural Biotechnology Journal|September 21, 2020
Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogensMaytham Hussein, Xiaohan Hu, Olivia K A Paulin, et al.
Plos One|November 15, 2014
Suppression of enhanced physiological tremor via stochastic noise: initial observationsCarlos Trenado, Florian Amtage, Frank Huethe, et al.
BMJ Open|January 17, 2020
Development and evaluation of a patient decision aid for patients considering ongoing medical or surgical treatment options for ulcerative colitis using a mixed-methods approach: protocol for DISCUSS studyDaniel Mark Baker, Matthew James Lee, Anne-Mairead Folan, et al.
Msystems|May 28, 2020
The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics StudyMaytham Hussein, John A Karas, Elena K Schneider-Futschik, et al.
Pageof 19